• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Diabetes Investig . HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019

tetano

Editor, Senior Moderator
J Diabetes Investig


. 2021 Dec 27.
doi: 10.1111/jdi.13743. Online ahead of print.
HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019


Shinnosuke Yanagisawa[SUP] 1 [/SUP], Yoichi Oikawa[SUP] 1 [/SUP], Sotaro Takagi[SUP] 1 [/SUP], Yuta Horikoshi[SUP] 1 [/SUP], Atsushi Satomura[SUP] 1 [/SUP], Kazuo Imai[SUP] 2 [/SUP], Jun Sakai[SUP] 2 [/SUP], Noriomi Ishibashi[SUP] 2 [/SUP], Norihito Tarumoto[SUP] 2 [/SUP], Shinichiro Iida[SUP] 3 [/SUP], Hideto Nakayama[SUP] 4 [/SUP], Yoshiyuki Haga[SUP] 5 [/SUP], Shigefumi Maesaki[SUP] 2 [/SUP], Akira Shimada[SUP] 1 [/SUP]



Affiliations

Abstract

Introduction: Many clinical studies have identified significant predictors or risk factors for the severity or mortality of coronavirus disease 2019 (COVID-19) cases. However, there are very limited reports on the risk factors for requiring oxygen therapy during hospitalization. In particular, we sought to investigate whether plasma glucose and HbA1c levels could be risk factors for oxygen therapy requirement.
Materials and methods: We conducted a single-center, retrospective study of 131 COVID-19 patients hospitalized at Saitama Medical University Hospital between March 2020 and November 2020. To identify the risk factors for oxygen therapy requirement during hospitalization, we performed a stepwise multivariate binary logistic regression analysis using several clinical parameters commonly obtained on admission, including plasma glucose and HbA1c levels.
Results: Of the 131 patients with COVID-19, 33.6% (44/131) received oxygen therapy during hospitalization. According to the logistic regression analysis, male sex (odds ratio [OR]: 8.76, 95% confidence interval [CI]: 1.65-46.5, p<0.05), age (OR: 1.07, 95% CI: 1.02-1.12, p<0.01), HbA1c levels (OR: 1.94, 95% CI: 1.09-3.44, p<0.05), and serum C-reactive protein (CRP) levels (OR: 2.22, 95% CI: 1.54-3.20, p<0.01) emerged as independent variables associated with oxygen therapy requirement during hospitalization.
Conclusions: In addition to male sex, age, and serum CRP levels, HbA1c levels on admission may serve as a risk factor for oxygen therapy requirement during the clinical course of COVID-19, irrespective of diabetes history and status. This may contribute to the efficient delegation of limited numbers of hospital beds to patients at risk for oxygen therapy requirement.

Keywords: Coronavirus disease 2019 (COVID-19); glycated hemoglobin (HbA1c); oxygen therapy; risk factor.
 
Back
Top Bottom